Clinical Distribution and Drug Susceptibility Characterization of Invasive Candida Isolates in a Tertiary Hospital of Xinjiang Province

References

• Lamoth F. Novel therapeutic approaches to invasive candidiasis: considerations for the clinician. Infect Drug Resist. 2023;16:1087–1097. doi:10.2147/IDR.S375625
   PubMed Web of Science ®Google Scholar
• Lee Y, Puumala E, Robbins N, Cowen LE. Antifungal drug resistance: molecular mechanisms in candida albicans and beyond. Chem Rev. 2021;121(6):3390–3411. doi:10.1021/acs.chemrev.0c00199
   PubMed Web of Science ®Google Scholar
• Koehler P, Stecher M, Cornely OA, et al. Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis. Clin Microbiol Infect. 2019;25(10):1200–1212. doi:10.1016/j.cmi.2019.04.024
   PubMed Web of Science ®Google Scholar
• CLSI M60. Performance Standards for Antifungal Susceptibility Testing of Yeasts. M60Ed2E.pdf.2020.
   Google Scholar
• CLSI M59. Epidemiological cutoff values for antifungal susceptibility testing,3rd edition, M59 Ed3E.pdf. 2020.
   Google Scholar
• Katoh K, Standley DM. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 2013;30(4):772–780. doi:10.1093/molbev/mst010
   PubMed Web of Science ®Google Scholar
• Price MN, Dehal PS, Arkin AP. FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol Biol Evol. 2009;26(7):1641–1650. doi:10.1093/molbev/msp077
   PubMed Web of Science ®Google Scholar
• Letunic I, Bork P. Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res. 2021;49(W1):W293–W296. doi:10.1093/nar/gkab301
   PubMed Web of Science ®Google Scholar
• Arendrup MC, Patterson TF. Multidrug-resistant candida: epidemiology, molecular mechanisms, and treatment. J Infect Dis. 2017;216(suppl_3):S445–S451. doi:10.1093/infdis/jix131
   PubMed Web of Science ®Google Scholar
• Leroy O, Bailly S, Gangneux JP, et al. Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study. Ann Intensive Care. 2016;6(1):2. doi:10.1186/s13613-015-0103-7
   PubMed Web of Science ®Google Scholar
• Wang Y, Zou Y, Chen X, et al. Innate immune responses against the fungal pathogen candida auris. Nat Commun. 2022;13(1):3553. doi:10.1038/s41467-022-31201-x
   PubMed Web of Science ®Google Scholar
• Du H, Bing J, Xu X, et al. Candida vulturna outbreak caused by cluster of multidrug-resistant strains, China. Emerg Infect Dis. 2023;29(7):1425–1428. doi:10.3201/eid2907.230254
   PubMed Web of Science ®Google Scholar
• Dekkers BGJ, Veringa A, Marriott DJE, et al. Invasive candidiasis in the elderly: considerations for drug therapy. Drugs Aging. 2018;35(9):781–789. doi:10.1007/s40266-018-0576-9
   PubMed Web of Science ®Google Scholar
• Barantsevich N, Barantsevich E. Diagnosis and Treatment of Invasive Candidiasis. Antibiotics. 2022;11(6):718. doi:10.3390/antibiotics11060718
   Google Scholar
• Song Y, Chen X, Yan Y, Wan Z, Liu W, Li R. Prevalence and antifungal susceptibility of pathogenic yeasts in China: a 10-year retrospective study in a teaching hospital. Front Microbiol. 2020;11:1401. doi:10.3389/fmicb.2020.01401
   PubMed Web of Science ®Google Scholar
• Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ. Invasive candidiasis. Nat Rev Dis Primers. 2018;4(1):18026. doi:10.1038/nrdp.2018.26
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Turnidge JD, Castanheira M, Jones RN. Twenty years of the SENTRY antifungal surveillance program: results for candida species from 1997–2016. Open Forum Infect Dis. 2019;6(Suppl 1):S79–S94. doi:10.1093/ofid/ofy358
   PubMedGoogle Scholar
• McTaggart LR, Cabrera A, Cronin K, Kus JV. Antifungal susceptibility of clinical yeast isolates from a large Canadian reference laboratory and application of whole-genome sequence analysis to elucidate mechanisms of acquired resistance. Antimicrob Agents Chemother. 2020;64(9):e00402–20. doi:10.1128/AAC.00402-20
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Carvalhaes CG, DeVries S, Huband MD, Castanheira M. Elderly versus nonelderly patients with invasive fungal infections: species distribution and antifungal resistance, SENTRY antifungal surveillance program 2017–2019. Diagn Microbiol Infect Dis. 2022;102(4):115627. doi:10.1016/j.diagmicrobio.2021.115627
   PubMed Web of Science ®Google Scholar
• Xiao M, Sun ZY, Kang M, et al. Five-year national surveillance of invasive candidiasis: species distribution and azole susceptibility from the china hospital invasive fungal surveillance net (CHIF-NET) study. J Clin Microbiol. 2018;56(7):e00577–18. doi:10.1128/JCM.00577-18
   PubMed Web of Science ®Google Scholar
• Xiao M, Chen SCA, Kong F, et al. Distribution and antifungal susceptibility of candida species causing candidemia in China: an update from the CHIF-NET study. J Infect Dis. 2020;221(Suppl 2):S139–S147. doi:10.1093/infdis/jiz573
   PubMedGoogle Scholar
• Huixia Y, Na S, Yumei L, et al. Distribution and drug resistance of clinical Candida infection. Int J Lab Med. 35(21):2997–2998. Chinese.
   Google Scholar
• Aibibai A, Zhihua M, Daiqin X, Peiru X. Clinical characteristics and risk factors for bloodstream infection analysis of invasive candidiasis in children in Urumqi. Chin J Contemp Pediatr. 2017;19(4):414–418. Chinese.
   Google Scholar
• Xia J, Huang W, Lu F, Li M, Wang B. Comparative analysis of epidemiological and clinical characteristics between invasive Candida infection versus colonization in critically Ill patients in a tertiary hospital in Anhui, China. Infect Drug Resist. 2022;15:3905–3918. doi:10.2147/IDR.S368792
   PubMed Web of Science ®Google Scholar
• Kullberg BJ, Arendrup MC, Campion EW. Invasive Candidiasis. N Engl J Med. 2015;373(15):1445–1456. doi:10.1056/NEJMra1315399
   PubMed Web of Science ®Google Scholar
• Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A. The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis. 2017;17(12):e383–e392. doi:10.1016/S1473-3099(17)30316-X
   PubMed Web of Science ®Google Scholar
• Fan X, Xiao M, Liao K, et al. Notable Increasing trend in azole non-susceptible Candida tropicalis causing invasive candidiasis in China (August 2009 to July 2014): molecular epidemiology and clinical azole consumption. Front Microbiol. 2017;8:464. doi:10.3389/fmicb.2017.00464
   PubMed Web of Science ®Google Scholar
• Zeng X, Peng M, Liu G, et al. Strain distribution and drug susceptibility of invasive fungal infection in clinical patients with systemic internal diseases. Front Bioeng Biotechnol. 2021;8:625024. doi:10.3389/fbioe.2020.625024
   PubMed Web of Science ®Google Scholar
• Ao K, Deng J, Liu Y, et al. Distribution and drug susceptibility analysis of pathogenic bacteria for fungal bloodstream infection in 19tertiary first-class general hospitals in Sichuan. China Trop Med. 2022;22(12):1188–1193. Chinese.
   Google Scholar
• Xia J, Wang Z, Li T, et al. Immunosuppressed patients with clinically diagnosed invasive fungal infections: the fungal species distribution, antifungal sensitivity and associated risk factors in a tertiary hospital of Anhui province. Infect Drug Resist. 2022;15:321–333. doi:10.2147/IDR.S351260
   PubMed Web of Science ®Google Scholar
• Mu N, Zhen N, Wang Y, et al. Analysis of the distribution and drug resistance of pathogenic bacteria in deep fungal infections in Hengshui City from 2017 to 2019. Chin J Disinfection. 2021;38(3):182–188. Chinese.
   Google Scholar
• Alexander BD, Johnson MD, Pfeiffer CD, et al. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis. 2013;56(12):1724–1732. doi:10.1093/cid/cit136
   PubMed Web of Science ®Google Scholar
• Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;62(4):e1–50. doi:10.1093/cid/civ933
   PubMed Web of Science ®Google Scholar
• Martin-Loeches I, Antonelli M, Cuenca-Estrella M, et al. ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients. Intensive Care Med. 2019;45(6):789–805. doi:10.1007/s00134-019-05599-w
   PubMed Web of Science ®Google Scholar